Pericardial Tamponade following Asymptomatic SARS-CoV-2 Infection: A Diagnostic Journey

Table 1

Laboratory assessment at admission and follow-up.

	Reference range	Admission	Follow-up
Hemoglobin	13.5–18.0 g/dl	13.5	10.1
Leucocytes	4.0–9.0/nl	12.5	5.9
Lymphocytes	1.1–4.0/nl	0.38	0.77
Platelet count	150–450/nl	195	260
Serum-creatinine	0.55–1.10 mg/dl	0.68	0.47
Serum-urea	16.6–48.5 mg/dl	82.6	27.8
CRP	<0.5 mg/dl	9	1
Interleukin-6	<7 pg/ml	115	—
PCT	mg/dl	0.35	—
NT-pro-BNP	<879 pg/ml	159	762
hsTropT	<0.014 ng/ml	0.026	0.037
LDH	135–225 U/l	483	221
D-dimer	<0.70 mg/l FEU	10.54	1.52
ESR (1 h)	<21 mm/h		56
GOT	<50 U/l	280	14
GPT	<50 U/l	391	12
Bilirubin	<1.20 mg/dl	2.63	0.74
ANA (IFT)	<1 : 100	1 : 100	1 : 320
ANCA (IFT)	<1 : 10	Negative	Negative
Ro52		High positivity	High positivity
nRNP/Sm		Borderline positivity	Negative
SARS-CoV-2 RT-PCR		Negative	Positive
SARS-CoV-2 ct		—	35.5
SARS-CoV-2-IgG		Positive	—
Adenovirus (ELISA)		IgG/IgM negative	—
HHV-6 (IFT)		IgG positive, IgM negative	—
CMV (CMIA)		IgG/IgM negative	—
Parvovirus B19 (CLIA)		IgG/IgM negative	—